Human Adipose Tissue-Derived Stromal Cells Ameliorate Adriamycin-Induced Nephropathy by Promoting Angiogenesis

References

• Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11:76–15. doi:10.1038/nrneph.2014.216.
   PubMed Web of Science ®Google Scholar
• Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton). 2011;16(1):30–38. doi:10.1111/j.1440-1797.2010.01383.x.
   PubMed Web of Science ®Google Scholar
• Hori H, Sakai K, Ohashi A, Nakai S. Chitin powder enhances growth factor production and therapeutic effects of mesenchymal stem cells in a chronic kidney disease rat model. J Artif Organs. 2023;26(3):203–11. doi:10.1007/s10047-022-01346-z.
   PubMed Web of Science ®Google Scholar
• Xia C, Shao L, Ma Y, Wang X, Zhang Y, Shi C, Li H, Wang J. Ultrasound-guided transplantation of mesenchymal stem cells improves adriamycin nephropathy in rats through the RIPK3/MLKL and TLR-4/NF-κB signaling. Stem Cells Dev. 2021;30(20):1003–16. doi:10.1089/scd.2021.0087.
   PubMed Web of Science ®Google Scholar
• Chen F, Chen N, Xia C, Wang H, Shao L, Zhou C, Wang J. Mesenchymal stem cell therapy in kidney diseases: potential and challenges. Cell Transplant. 2023;32:9636897231164251. doi:10.1177/09636897231164251.
   Web of Science ®Google Scholar
• Qiu Y, Lei C, Zeng J, Xie Y, Cao Y, Yuan Q, Su H, Zhang Z, Zhang C. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin. Mol Ther. 2023;31(11):3337–54. doi:10.1016/j.ymthe.2023.09.003.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang X, Wu H, Ma Z, Liu X, Ma J, Zhang D, Sheng L, Chen X, Zhang S. et al. Hydrangea paniculata coumarins attenuate experimental membranous nephritis by bidirectional interactions with the gut microbiota. Commun Biol. 2023;6(1):1189. doi:10.1038/s42003-023-05581-9.
   PubMed Web of Science ®Google Scholar
• Deluque AL, Oliveira BM, Souza CS, Maciel ALD, Francescato HDC, Giovanini C, de Almeida LF, de Paula FJA, Costa RS, Antunes-Rodrigues J., et al. Paricalcitol improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 signaling pathways in adriamycin-induced nephropathy. Nutrients. 2022;14(24):5316. doi:10.3390/nu14245316.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, Wang Y. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493–507. doi:10.1038/s41581-018-0023-5.
   PubMed Web of Science ®Google Scholar
• Zheng J, Lu Y, Lin Y, Si S, Guo B, Zhao X, Cui L. Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond. Cell Death Differ. 2024;31(1):9–27. doi:10.1038/s41418-023-01238-6.
   PubMed Web of Science ®Google Scholar
• Han L, Wu X, Wang O, Luan X, Velander WH, Aynardi M, Halstead ES, Bonavia AS, Jin R, Li G., et al. Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution. Theranostics. 2023;13(9):2843–62. doi:10.7150/thno.83942.
   PubMed Web of Science ®Google Scholar
• Chen J, Fujita N, Takeda T, Hanyu W, Takatani H, Nakagawa T, Nishimura R. Canine bone marrow peri-adipocyte cells could therapeutically benefit acute spinal cord injury through migration and secretion of hepatocyte growth factor to inflammatory milieu. Exp Anim. 2023;72(1):19–29. doi:10.1538/expanim.22-0026.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang Y, Wang D, Xu X, Xu J, Yang X, Qian H, Zhang H. Basic fibroblast growth factor promotes mesenchymal stem cell migration by regulating glycolysis-dependent β-catenin signaling. Stem Cells. 2023;41(6):628–42. doi:10.1093/stmcls/sxad024.
   PubMed Web of Science ®Google Scholar
• Xu T, Chen T, Fang H, Shen X, Shen X, Tang Z, Zhao J. Human umbilical cord mesenchymal stem cells repair endothelial injury and dysfunction by regulating NLRP3 to inhibit endothelial cell pyroptosis in Kawasaki disease. Inflammation. 2023;47:483–502.
   PubMed Web of Science ®Google Scholar
• Qi R, Hou J, Yang Y, Yang Z, Wu L, Qiao T, Wang X, Song D. Integrin beta1 mediates the effect of telocytes on mesenchymal stem cell proliferation and migration in the treatment of acute lung injury. J Cell Mol Med. 2023;27(24):3980–94. doi:10.1111/jcmm.17976.
   PubMed Web of Science ®Google Scholar
• Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells (Dayton, Ohio). 2011;29(6):913–19. doi:10.1002/stem.643.
   PubMed Web of Science ®Google Scholar
• Giacca M, Zacchigna S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 2012;19(6):622–29. doi:10.1038/gt.2012.17.
   PubMed Web of Science ®Google Scholar
• Herrera M, Mirotsou M. Stem cells: potential and challenges for kidney repair. Am J Physiol Renal Physiol. 2014;306:F12–23. doi:10.1152/ajprenal.00238.2013.
   PubMed Web of Science ®Google Scholar
• Rochette L, Mazini L, Malka G, Zeller M, Cottin Y, Vergely C. The crosstalk of adipose-derived stem cells (ADSC), oxidative stress, and inflammation in protective and adaptive responses. Int J Mol Sci. 2020;21(23):21. doi:10.3390/ijms21239262.
   Web of Science ®Google Scholar
• Yu S, Cheng Y, Zhang L, Yin Y, Xue J, Li B, Gong Z, Gao J, Mu Y. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats. Stem Cell Res Ther. 2019;10(1):333. doi:10.1186/s13287-019-1474-8.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Liu HY, Chang YT, Cheng YH, Mersmann HJ, Kuo WH, Ding S-T. Isolation and differentiation of adipose-derived stem cells from porcine subcutaneous adipose tissues. J Vis Exp. 2016;(109):e53886. doi:10.3791/53886-v.
   PubMed Web of Science ®Google Scholar
• Mailey B, Hosseini A, Baker J, Young A, Alfonso Z, Hicok K, Wallace AM, Cohen SR. Adipose-derived stem cells: methods for isolation and applications for clinical use. Methods Mol Biol. 2014;1210:161–81.
   PubMedGoogle Scholar
• Wang W, Sheng L, Chen Y, Li Z, Wu H, Ma J, Zhang D, Chen X, Zhang S. Total coumarin derivates from Hydrangea paniculata attenuate renal injuries in cationized-BSA induced membranous nephropathy by inhibiting complement activation and interleukin 10-mediated interstitial fibrosis. Phytomedicine. 2022;96:153886. doi:10.1016/j.phymed.2021.153886.
   PubMed Web of Science ®Google Scholar
• Shi X, Li Z, Lin W, Shi W, Hu R, Chen G, Li X, Li X, Zhang S. Altered intestinal microbial flora and metabolism in patients with idiopathic membranous nephropathy. Am J Nephrol. 2023;54(11–12):451–70. doi:10.1159/000533537.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ma J, Sheng L, Zhang D, Chen X, Yang J, Wang D. Total coumarins from hydrangea paniculata show renal protective effects in lipopolysaccharide-induced acute kidney injury via anti-inflammatory and antioxidant activities. Front Pharmacol. 2017;8. doi:10.3389/fphar.2017.00872.
   Web of Science ®Google Scholar
• Zhang Y, He W, Zhang S. Seeking for correlative genes and signaling pathways with bone metastasis from breast cancer by integrated analysis. Front Oncol. 2019;9. doi:10.3389/fonc.2019.00138.
   Web of Science ®Google Scholar
• Sen Z, Weida W, Jie M, Li S, Dongming Z, Xiaoguang C. Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2/3-mediated profibrosis. Phytomedicine. 2019;57:385–95. doi:10.1016/j.phymed.2018.12.045.
   PubMed Web of Science ®Google Scholar
• Zhu M, Heydarkhan-Hagvall S, Hedrick M, Benhaim P, Zuk P. Manual isolation of adipose-derived stem cells from human lipoaspirates. J Vis Exp. 2013;(79):e50585. doi:10.3791/50585-v.
   PubMed Web of Science ®Google Scholar
• Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6(12):2173–85. doi:10.1002/sctm.17-0129.
   PubMed Web of Science ®Google Scholar
• Lopes-Pacheco M, Rocco PRM. Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases. Front Pharmacol. 2023;14:1067422. doi:10.3389/fphar.2023.1067422.
   PubMed Web of Science ®Google Scholar
• Shin JI, Kronbichler A, Oh J, Meijers B. Nephrotic syndrome: genetics, mechanism, and therapies. Biomed Res Int. 2018;2018:6215946. doi:10.1155/2018/6215946.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Z, Wu H, Wang J, Zhang S. Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway. J Ethnopharmacol. 2022;288:115004. doi:10.1016/j.jep.2022.115004.
   PubMed Web of Science ®Google Scholar
• Shi W, Li Z, Wang W, Liu X, Wu H, Chen X, Zhou X, Zhang S. Dynamic gut microbiome-metabolome in c-BSA induced experimental immune-complex glomerulonephritis and effect of losartan and MMF on microbiota modulation. J Pharmaceut Anal. 2023;14(4):100931. doi:10.1016/j.jpha.2023.12.021.
   PubMedGoogle Scholar
• Yogavijayan Kandasamy RS, Lumbers ER, Rudd D. Nephrin – a biomarker of early glomerular injury. Biomarker Res. 2014;2(1):21. doi:10.1186/2050-7771-2-21.
   PubMedGoogle Scholar
• D’Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398–411. doi:10.1056/NEJMra1106556.
   PubMed Web of Science ®Google Scholar
• Angeletti A, Cantarelli C, Petrosyan A, Andrighetto S, Budge K, D’Agati VD, Hartzell S, Malvi D, Donadei C, Thurman JM., et al. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis. J Experiment Medi. 2020;217(9). doi:10.1084/jem.20191699.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yuan J, Zhou B, Lee AJ, Lee AJ, Ghawji M Jr., Yoo TJ. The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology. 2011;133(1):133–40. doi:10.1111/j.1365-2567.2011.03421.x.
   PubMed Web of Science ®Google Scholar
• Han HS, Lee H, You D, Nguyen VQ, Song DG, Oh BH, Shin S, Choi JS, Kim JD, Pan CH., et al. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. J Control Release. 2020;320:328–36. doi:10.1016/j.jconrel.2020.01.042.
   PubMed Web of Science ®Google Scholar
• Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. Smad7 inhibits fibrotic effect of TGF-β on Renal tubular epithelial cells by blocking smad2 activation. J Am Soci Nephro. 2002;13(6):1464–72. doi:10.1097/01.ASN.0000014252.37680.E4.
   PubMed Web of Science ®Google Scholar
• Koellensperger E, Gramley F, Preisner F, Leimer U, Germann G, Dexheimer V. Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications. Stem Cell Res Ther. 2014;5(3):65. doi:10.1186/scrt454.
   PubMedGoogle Scholar